medigraphic.com

2014, Number 4

<< Back Next >>

Enf Infec Microbiol 2014; 34 (4)

Risk behaviors and level of knowledge about human papillomavirus in Northeastern University, Argentina

Medina ML, Medina MG, Merino LA

Language: Spanish
References: 28
Page: 140-144
PDF size: 144.91 Kb.


ABSTRACT

Introduction. The Human Papillomavirus (HPV) is a sexually transmitted disease, college students still vulnerable to this disease population.
Objective. To describe key risk behaviors and level of knowledge about HPV among university students. Materials and methods. Faculty of Dentistry students of Northeastern University were selected during 2010. After informed consent, anonymous questionnaire on sexual risk behavior and knowledge of HPV was used. The data were processed by statistical program.
Results. They were 61 students including; 47 (77%) women and 14 (23%) men. Mean age (22 years). It was observed that 36 (59%) had sex early. In 41 (67%) reported having had two or more sexual partners. It was observed that 26 (43%) never or rarely used condoms. Of the total 33 (54%) reported oral sex; 25 (41%) did not consume oral contraceptives. Alcohol consumption was observed in 31 (51%). Knowledge about HPV in the basic academic level was insufficient to 67% good and clinical academic level was 61% of very good to excellent. The greatest ignorance was: 33 (54%) types of injuries; 33 (54%) treatment; 32 (52%) risk factors; 30 (49%) preventive methods.
Conclusion. The main risk behaviors HPV infection in this population were to have had two or more sexual partners, oral sex and alcohol. High ignorance was observed, may be the main risk factor for acquiring the infection.


REFERENCES

  1. Sánchez M, Uribe F, Conde C. #La infección por el virus del papiloma humano, un posible marcador biológico de comportamiento sexual en estudiantes universitarios.” Salud Pública de Mex 2002;44:442-447.

  2. Castro M, Arellano M. “Acceso a la información de mujeres con VPH, displasia y cáncer cervical in situ”. Salud Pública Mex 2010; 52:207-212.

  3. Castro I. “Conocimientos y factores de riesgo sobre infecciones de transmisión sexual en adolescentes”. Rev Haban Cienc Méd 2010; 9(5):705-716.

  4. Montero A, González E, Molina T. “Salud sexual y reproductiva de los y las adolescentes en Chile”. Rev Chil Salud Pública 2008;12:42-47.

  5. Kahn J, Ding L, Huang B, Zimet G, Rosenthal S, Frazier L. “Mothers’ intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses”. Pediatrics 2009; 123:1439-1445.

  6. Denny-Smith T, Bairan A, Page M. “A survey of female nursing students’ knowledge, health beliefs, perceptions of risk, and risk behaviors regarding human papillomavirus and cervical cancer”. J Am Acad Nurse Pract 2006;18:62-69.

  7. Barbosa L, Bezerra A, Teixeira M. “Ser mulher portadora do HPV: umaabordagem cultural”. Rev Esc Enferm 2008; 42:737-743.

  8. Lee E, Tripp-Reimer T, Miller A, Sadler GR, Lee SY. “Korean American women’s beliefs about breast and cervical cancer and associated symbolic meanings”. Oncol Nurse Forum 2007;34:713-720.

  9. Donoso E, Cuello M, Villarroel L. “Reducción de la mortalidad por cáncer cérvico uterino en Chile, 1990-2003”. Rev Chil Obstet Ginecol 2006;71:307-312.

  10. De Acevedo S, Antero Sousa M, Vieira N. “Motivos que levanmulheres a nao retornarem para receber o resultado de examen Papanicolaou”. Rev Latino-am Enfermagen 2006;14:503-509.

  11. Urrutia MT, Poupin L, Concha X, Vinales D, Iglesia C, Reyes V. “¿Por qué las mujeres no se toman el Papanicolau?: Barreras percibidas por un grupo de mujeres ingresadas al programa de cáncer cervicouterino AUGE”. Rev Chil Obstet Ginecol 2008;73:98-103.

  12. Rubio D, Restrepo M. “Creencias en salud en mujeres universitarias relacionadas a la toma de citología vaginal”. Rev Colomb Psicol 2004;13:102-112.

  13. Sankaranarayanan, R., A. M. Budukh, and R. Rajkumar. “Effective screening programmes for cervical cancer in low- and middle-income developing countries”. Bulletin of the World Health Org 2001; 79 (9):54-62.

  14. Tacken, M. A., J. C. Braspenning, R. P. Hermens, P. M. Spreeuwenberg, H. J. van den Hoogen, D. H. de Bakker, et al. 2007. “Uptake of cervical cancer screening in The Netherlands is mainly influenced by women’s beliefs about the screening and by the inviting organization”. European J of Public Health 17:178-185.

  15. Arrossi, S., and M. Paolino. 2008. “Argentina. Diagnóstico de Situación del Programa Nacional de Prevención de Cáncer de Cuello de Útero, y Programas Provinciales”. Publicación Nı 64-Organización Panamericana de la Salud (OPS/OMS). Buenos Aires.

  16. Paolino MA & Arrossi S. “Women’s Knowledge About Cervical Cancer, Pap Smear and Human Papillomavirus and Its Relation to Screening in Argentina”, Women & Health, 2011; 51 (1): 72-87.

  17. Arrossi, S., S. Ramos, M. Paolino, and R. Sankaranarayanan. “Social inequality in Pap smear coverage: Identifying under-users of cervical cancer screening in Argentina”. Reproductive Health Matters 2008; 32:50-58.

  18. Arrossi, S., and M. Paolino. “Argentina. Diagnóstico de Situación del Programa Nacional de Prevención de Cáncer de Cuello de Útero, y Programas Provinciales”. Publicación Organización Panamericana de la Salud (OPS/OMS) 2008.Buenos Aires.

  19. Arbyn M, Raifu AO, Bray F, Weiderpass E, Antila A. “Trends of cervical cancer mortality in the member states of the European Union”. Eur J Cancer. 2009;45:2640-2648.

  20. Arrossi S, Paolino M. “Proyecto para el mejoramiento del Programa Nacional de Prevención de Cáncer de Cuello Uterino en Argentina: Diagnóstico de situación del Programa Nacional de Prevención de Cáncer de Cuello de Útero, y Programas Provinciales”. Buenos Aires: Organización Panamericana de la Salud; 2008. (Informe Técnico No. 64).

  21. Holland-Barkis P, Forjuoh S, Couchman G, Capen C, Rascoe T, Reis M. “Primary care physicians’ awareness and adherence to cervical cancer screening guidelines in Texas”. Prev Med. 2006;42:140-145.

  22. Arrossi S, Paolino M, Sankaranarayanan R. “Challenges faced by cervical cancer prevention programs in developing countries: a situational analysis of program organization in Argentina”. Rev Panam Salud Publica. 2010;28(4):249-257. Arrossi S, Maceira V, Paolino M, Sankaranarayanan R.

  23. “Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: a population- based survey”. Vaccine, 30(14):2467-74, 2012.

  24. Hernández-Carreño L, Padilla-Loredo S, Quintero-Soto ML. “Factores de riesgo en adolescentes para contraer el Virus del Papiloma Humano”. Revista Digital Universitaria 2012; 13(9): 1-17.

  25. Tirado L, Mohar A, López M, García, Franco F, Borgues G. “Factores de riesgo de cáncer cervicouterino invasor en mujeres mexicanas”. Salud Pública de Mex 2005; 47: 342-350.

  26. Melo G, Waliszewski S. “El virus del papiloma humano”. Revista de Divulgación Científica y Tecnológica de la Universidad Veracruzana, 2009. Disponible en: http:// www.uv.mx/cienci ahombre/revistae/vol2 2num2/articulos/ virus/index.html.

  27. León G, Bosques O, Silveira P, De la Torre A, Soto P y Rodriguez B. “Incidencia de los factores en mujeres cubanas con diagnóstico de cérvix”. Instituto Nacional de Oncología y Radiobiología 2009; 1: 1-9.

  28. Cameron JE, Mercante D, O´Brien M,Gaffga A, Leigh J, Janet E, Fidel PL, Hagensee ME. “The impact of highly active antiretroviral therapy and inmmnodeficiency on Human Papillomavirus infection of the oral cavity of human Inmnodeficiency virus-Seropositive adults”. Sexually Transmitted Diseases 2005; 32 (11): 703-709.




2020     |     www.medigraphic.com